Clinical Trials · NCT01843075
Evaluating Liraglutide in Alzheimer's Disease
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Imperial College London
- Enrollment
- 204
- Start date
- Jan 2014
- Locations
- 1 site, United Kingdom
- Primary endpoint
- The change in cerebral glucose metabolic rate